P

Planet Innovation

Healthtech product development and commercialization services

Overview

Planet Innovation provides end-to-end healthtech product development and commercialization services, covering market opportunity assessment, design and engineering, digital solutions, manufacturing, and go-to-market launch. Its process takes a product from identifying a market need through to scalable manufacturing and a commercial launch, usually via project-based work or long-term partnerships. The company distinguishes itself with an integrated, full-spectrum service model and expanded medtech manufacturing capacity, including the BIT acquisition that doubled its North American operations. Its goal is to help healthtech innovations reach customers efficiently and achieve sustainable commercial success.

Work here?Claim your company

About Planet Innovation

Simplify's Rating
Why Planet Innovation is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

ConsultingIndustrial & ManufacturingHealthcare

Company Size

201-500

Company Stage

Late Stage VC

Total Funding

$13M

Headquarters

Melbourne VIC, Australia

Founded

2009

Get referred to Planet Innovation

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • Meiban's 100 percent ownership gives PI immediate access to seven manufacturing sites.
  • PI's LevitasBio and NeoSync wins show repeatable commercialization capability across diagnostics and instruments.
  • The combined CDMO fixes a common medtech handoff problem, supporting larger, stickier contracts.

What critics are saying

  • Meiban now owns PI entirely; integration failures can trigger client defections in 2027.
  • Independent PI culture faces dilution inside Meiban, risking attrition among senior engineers and founders.
  • Medtech customers can shift to Jabil, Flex, or Integer if PI loses speed.

What makes Planet Innovation unique

  • Meiban completed acquisition October 2026, pairing PI development with global manufacturing scale.
  • PI runs FDA-registered, ISO 13485 facilities in Melbourne and Irvine, California.
  • Its team designs regulated devices from concept through commercial launch for medtech clients.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$13M

Above

Industry Average

Funded Over

3 Rounds

Late VC funding comparison data is currently unavailable. We're working to provide this information soon!
Late VC Funding Comparison Coming Soon

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Company Match
  • Paid Vacation
  • Paid Holidays
  • Paid Sick Leave
  • Life Insurance
  • Disability Insurance

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

-1%
Legal Desire
Nov 10th, 2026
Herbert Smith Freehills Kramer advises Meiban Group on the acquisition of Planet Innovation.

Herbert Smith Freehills Kramer advises Meiban Group on the acquisition of Planet Innovation. * Author Cynthia Lydia Marbaniang * Published November 10, 2026 Herbert Smith Freehills Kramer (HSF Kramer) has advised Meiban Group (Meiban) on its acquisition of Planet Innovation by way of scheme of arrangement. Meiban is a global contract development and manufacturing organisation offering a comprehensive range of product development and advanced manufacturing capabilities. Meiban has global operations throughout Asia, the United States, Europe and Australia with facilities across Singapore and Malaysia, specialising in high-volume, precision manufacturing for the medtech sector. Founded in Melbourne, Planet Innovation is a medtech product development company, partnering with medtech companies globally to design, develop and manufacture regulated medical devices in its facilities in Australia and the United States. The transaction follows a strategic alliance announced by the companies in 2025, where Meiban acquired an initial ~19.9% stake in Planet Innovation. The transaction will enable the two parties to combine their complementary businesses into an integrated contract development and manufacturing organisation serving the global medtech sector. The HSF Kramer team was led by partner Jason Jordan and senior associate Damien Devnarain, with support from solicitors Sandra Nguyen and Rosalind Wei. Jason said, "It was a pleasure to work with the Meiban team on this transaction, supporting its entry into the Australian market and its broader vision to improve lives through the products both organisations help bring to market." This transaction is another example of HSF Kramer's market-leading work in M&A. Other recent examples include advising: Where the legal industry reads first. No spam. Unsubscribe anytime. From Legal Desire Is your firm the one being cited, or the one being skipped? Legal Desire ran the test. On several everyday legal questions, software companies are answering and law firms are not. Legal Desire help firms fix that, and Legal Desire build the technology behind the practice. Lawyers and firms: get featured on Legal Desire. Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC. See the full deal record on DealDatabase The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record

Herbert Smith Freehills Kramer
Nov 9th, 2026
HSF Kramer advises Meiban Group on Planet Innovation acquisition to create medtech manufacturing group

Herbert Smith Freehills Kramer (HSF Kramer) has advised Meiban Group on its acquisition of Planet Innovation by way of a scheme of arrangement. No deal value was disclosed. Meiban is a global contract development and manufacturing organisation with facilities in Singapore and Malaysia, specialising in high-volume, precision manufacturing for the medtech sector. Planet Innovation, founded in Melbourne, designs, develops and manufactures regulated medical devices in Australia and the United States. The deal follows a 2025 strategic alliance in which Meiban bought an initial stake of about 19.9% in Planet Innovation. The two businesses will combine into an integrated contract development and manufacturing organisation serving the global medtech sector. Partner Jason Jordan and senior associate Damien Devnarain led the HSF Kramer team. Jordan said the deal supports Meiban's entry into the Australian market.

DealStreetAsia
Jul 17th, 2025
Dymon-backed Meiban picks up stake in Aussie medtech

Dymon has been looking to sell its stake in Meiban.

Benzinga
Nov 20th, 2024
Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis

Quantum-Si also partnered with Planet Innovation to develop and manufacture Proteus.

PR Newswire
Aug 5th, 2024
Asp Health Inc. Expands Executive Team With Its First National Sales Director

Patrick will build a sales team composed of direct representatives and channel partners, enabling our system to provide enhanced patient care in the field of oncology. -- ASP Health EVP and CCO Hari Subramanian, PhD, MBA

Recently Posted Jobs

Sign up to get curated job recommendations

Planet Innovation is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs